|
1
|
Hutchings C, Phillips JA and Djamgoz MBA:
Nerve input to tumours: Pathophysiological consequences of a
dynamic relationship. Biochim Biophys Acta Rev Cancer.
1874(188411)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cervantes-Villagrana RD, Albores-Garcia D,
Cervantes-Villagrana AR and García-Acevez SJ: Tumor-induced
neurogenesis and immune evasion as targets of innovative
anti-cancer therapies. Signal Transduct Target Ther.
5(99)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jiang SH, Hu LP, Wang X, Li J and Zhang
ZG: Neurotransmitters: Emerging targets in cancer. Oncogene.
39:503–515. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhu Y, Zhang GN, Shi Y, Cui L, Leng XF and
Huang JM: Perineural invasion in cervical cancer: Pay attention to
the indications of nerve-sparing radical hysterectomy. Ann Transl
Med. 7(203)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L,
Freedland SJ and Frenette PS: Autonomic nerve development
contributes to prostate cancer progression. Science.
341(1236361)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Deborde S, Omelchenko T, Lyubchik A, Zhou
Y, He S, McNamara WF, Chernichenko N, Lee SY, Barajas F, Chen CH,
et al: Schwann cells induce cancer cell dispersion and invasion. J
Clin Invest. 126:1538–1554. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Ayala GE, Dai H, Powell M, Li R, Ding Y,
Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, et al:
Cancer-related axonogenesis and neurogenesis in prostate cancer.
Clin Cancer Res. 14:7593–7603. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dai H, Li R, Wheeler T, Ozen M, Ittmann M,
Anderson M, Wang Y, Rowley D, Younes M and Ayala GE: Enhanced
survival in perineural invasion of pancreatic cancer: An in vitro
approach. Hum Pathol. 38:299–307. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Albo D, Akay CL, Marshall CL, Wilks JA,
Verstovsek G, Liu H, Agarwal N, Berger DH and Ayala GE:
Neurogenesis in colorectal cancer is a marker of aggressive tumor
behavior and poor outcomes. Cancer. 117:4834–4845. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huang D, Su S, Cui X, Shen X, Zeng Y, Wu
W, Chen J, Chen F, He C, Liu J, et al: Nerve fibers in breast
cancer tissues indicate aggressive tumor progression. Medicine
(Baltimore). 93(e172)2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao Q, Yang Y, Liang X, Du G, Liu L, Lu
L, Dong J, Han H and Zhang G: The clinicopathological significance
of neurogenesis in breast cancer. BMC Cancer.
14(484)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chowdary PD, Che DL and Cui B:
Neurotrophin signaling via long-distance axonal transport. Annu Rev
Phys Chem. 63:571–594. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vanderhaeghen P and Cheng HJ: Guidance
molecules in axon pruning and cell death. Cold Spring Harb Perspect
Biol. 2(a001859)2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mancino M, Ametller E, Gascon P and
Almendro V: The neuronal influence on tumor progression. Biochim
Biophys Acta. 1816:105–118. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Adriaenssens E, Vanhecke E, Saule P,
Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X and Hondermarck
H: Nerve growth factor is a potential therapeutic target in breast
cancer. Cancer Res. 68:346–351. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mandelker DL, Yamashita K, Tokumaru Y,
Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim
MS, et al: PGP9.5 promoter methylation is an independent prognostic
factor for esophageal squamous cell carcinoma. Cancer Res.
65:4963–4968. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lee YM, Lee JY, Kim MJ, Bae HI, Park JY,
Kim SG and Kim DS: Hypomethylation of the protein gene product 9.5
promoter region in gallbladder cancer and its relationship with
clinicopathological features. Cancer Sci. 97:1205–1210.
2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wen W, Liu G, Jin K and Hu X: TGF-β1
induces PGP9.5 expression in CAFs to promote the growth of
colorectal cancer cells. Oncol Rep. 37:115–122. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ohta T and Fukuda M: Ubiquitin and breast
cancer. Oncogene. 23:2079–2088. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dollé L, Adriaenssens E, El
Yazidi-Belkoura I, Le Bourhis X, Nurcombe V and Hondermarck H:
Nerve growth factor receptors and signaling in breast cancer. Curr
Cancer Drug Targets. 4:463–470. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bradshaw RA, Pundavela J, Biarc J,
Chalkley RJ, Burlingame AL and Hondermarck H: NGF and ProNGF:
Regulation of neuronal and neoplastic responses through receptor
signaling. Adv Biol Regul. 58:16–27. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liss MA, Gordon A, Morales B, Osann K,
Skarecky D, Lusch A, Zaldivar F and Ahlering TE: Urinary nerve
growth factor as an oncologic biomarker for prostate cancer
aggressiveness. Urol Oncol. 32:714–719. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mei F, Liu JY and Xue WC: Histological
grading of invasive breast carcinoma: Nottingham histological
grading system. Zhonghua Bing Li Xue Za Zhi. 48:659–664.
2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
24
|
Rao SJ, Rao JBM and Rao PJ:
Immunohistochemical analysis of stromal fibrocytes and
myofibroblasts to envision the invasion and lymph node metastasis
in oral squamous cell carcinoma. J Oral Maxillofac Pathol.
21:218–223. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dikmen M: Comparison of the effects of
curcumin and RG108 on NGF-induced PC-12 Adh cell differentiation
and neurite outgrowth. J Med Food. 20:376–384. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Schimmelpfeng J, Weibezahn KF and
Dertinger H: Quantification of NGF-dependent neuronal
differentiation of PC-12 cells by means of neurofilament-L mRNA
expression and neuronal outgrowth. J Neurosci Methods. 139:299–306.
2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chan GKL, Hu WWH, Zheng ZX, Huang M, Lin
YXY, Wang CY, Gong AGW, Yang XY, Tsim KWK and Dong TTX: Quercetin
potentiates the NGF-induced effects in cultured PC 12 cells:
Identification by HerboChips showing a binding with NGF. Evid Based
Complement Alternat Med. 1502457:2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cai S, Cheng X, Liu Y, Lin Z, Zeng W, Yang
C, Liu L, Chukwuebuka OA and Li W: EYA1 promotes tumor angiogenesis
by activating the PI3K pathway in colorectal cancer. Exp Cell Res.
367:37–46. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ernst BP, Mikstas C, Stover T, Stauber R
and Strieth S: Association of eIF4E and SPARC expression with
lymphangiogenesis and lymph node metastasis in hypopharyngeal
cancer. Anticancer Res. 38:699–706. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang J, Huang Y, Zhang J, Xing B, Xuan W,
Wang H, Huang H, Yang J and Tang J: NRP-2 in tumor
lymphangiogenesis and lymphatic metastasis. Cancer Lett.
418:176–184. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zanotto-Filho A, Rajamanickam S, Loranc E,
Masamsetti VP, Gorthi A, Romero JC, Tonapi S, Gonçalves RM, Reddick
RL, Benavides R, et al: Sorafenib improves alkylating therapy by
blocking induced inflammation, invasion and angiogenesis in breast
cancer cells. Cancer Lett. 425:101–115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL,
Dong XR, Zhang S, Zhang RG, Meng R, Zhu F and Wu G: Catecholamines
contribute to the neovascularization of lung cancer via
tumor-associated macrophages. Brain Behav Immun. 81:111–121.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kim-Fuchs C, Le CP, Pimentel MA,
Shackleford D, Ferrari D, Angst E, Hollande F and Sloan EK: Chronic
stress accelerates pancreatic cancer growth and invasion: A
critical role for beta-adrenergic signaling in the pancreatic
microenvironment. Brain Behav Immun. 40:40–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lamkin DM, Sloan EK, Patel AJ, Chiang BS,
Pimentel MA, Ma JC, Arevalo JM, Morizono K and Cole SW: Chronic
stress enhances progression of acute lymphoblastic leukemia via
β-adrenergic signaling. Brain Behav Immun. 26:635–641.
2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu Y, Yu X and Zhuang J: Epinephrine
stimulates cell proliferation and induces chemoresistance in
myeloma cells through the β-adrenoreceptor in vitro. Acta Haematol.
138:103–110. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang
D, Li T, Wang CZ, Tan YX, Ding J, et al: ADRB2 signaling promotes
HCC progression and sorafenib resistance by inhibiting autophagic
degradation of HIF1alpha. J Hepatol. 65:314–324. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lu R, Fan C, Shangguan W, Liu Y, Li Y,
Shang Y, Yin D, Zhang S, Huang Q, Li X, et al: Neurons generated
from carcinoma stem cells support cancer progression. Signal
Transduct Target Ther. 2(16036)2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Marusyk A and Polyak K: Tumor
heterogeneity: Causes and consequences. Biochim Biophys Acta.
1805:105–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
West NR, McCuaig S, Franchini F and Powrie
F: Emerging cytokine networks in colorectal cancer. Nat Rev
Immunol. 15:615–629. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mantovani A, Barajon I and Garlanda C:
IL-1 and IL-1 regulatory pathways in cancer progression and
therapy. Immunol Rev. 281:57–61. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Berraondo P, Sanmamed MF, Ochoa MC,
Etxeberria I, Aznar MA, Pérez-Gracia JL, Rodríguez-Ruiz ME,
Ponz-Sarvise M, Castañón E and Melero I: Cytokines in clinical
cancer immunotherapy. Br J Cancer. 120:6–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Galdiero MR, Marone G and Mantovani A:
Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol.
10(a028662)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Najafi M, Goradel NH, Farhood B, Salehi E,
Solhjoo S, Toolee H, Kharazinejad E and Mortezaee K: Tumor
microenvironment: Interactions and therapy. J Cell Physiol.
234:5700–5721. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yao M, Brummer G, Acevedo D and Cheng N:
Cytokine regulation of metastasis and tumorigenicity. Adv Cancer
Res. 132:265–367. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH
and Park MH: Interleukin 32, inflammation and cancer. Pharmacol
Ther. 174:127–137. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Setrerrahmane S and Xu H: Tumor-related
interleukins: Old validated targets for new anti-cancer drug
development. Mol Cancer. 16(153)2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Folkman J, Merler E, Abernathy C and
Williams G: Isolation of a tumor factor responsible for
angiogenesis. J Exp Med. 133:275–288. 1971.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Fischer C, Jonckx B, Mazzone M, Zacchigna
S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M,
De Mol M, et al: Anti-PlGF inhibits growth of
VEGF(R)-inhibitor-resistant tumors without affecting healthy
vessels. Cell. 131:463–475. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fischer C, Mazzone M, Jonckx B and
Carmeliet P: FLT1 and its ligands VEGFB and PlGF: Drug targets for
anti-angiogenic therapy? Nat Rev Cancer. 8:942–956. 2008.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Stacker SA, Baldwin ME and Achen MG: The
role of tumor lymphangiogenesis in metastatic spread. FASEB J.
16:922–934. 2002.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lala PK, Nandi P and Majumder M: Roles of
prostaglandins in tumor-associated lymphangiogenesis with special
reference to breast cancer. Cancer Metastasis Rev. 37:369–384.
2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Dieterich LC and Detmar M: Tumor
lymphangiogenesis and new drug development. Adv Drug Deliv Rev.
99:148–160. 2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Garnier L, Gkountidi AO and Hugues S:
Tumor-associated lymphatic vessel features and immunomodulatory
functions. Front Immunol. 10(720)2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Paduch R: The role of lymphangiogenesis
and angiogenesis in tumor metastasis. Cell Oncol (Dordr).
39:397–410. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Achen MG and Stacker SA: Tumor
lymphangiogenesis and metastatic spread-new players begin to
emerge. Int J Cancer. 119:1755–1760. 2006.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Seifert P, Benedic M and Effert P: Nerve
fibers in tumors of the human urinary bladder. Virchows Arch.
440:291–297. 2002.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Seifert P and Spitznas M: Axons in human
choroidal melanoma suggest the participation of nerves in the
control of these tumors. Am J Ophthalmol. 133:711–713.
2002.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ventura S, Pennefather J and Mitchelson F:
Cholinergic innervation and function in the prostate gland.
Pharmacol Ther. 94:93–112. 2002.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mitchell BS, Schumacher U, Stauber VV and
Kaiserling E: Are breast tumours innervated? Immunohistological
investigations using antibodies against the neuronal marker protein
gene product 9.5 (PGP 9.5) in benign and malignant breast lesions.
Eur J Cancer. 30A:1100–1103. 1994.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kayahara M, Nakagawara H, Kitagawa H and
Ohta T: The nature of neural invasion by pancreatic cancer.
Pancreas. 35:218–223. 2007.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Ayala GE, Wheeler TM, Shine HD, Schmelz M,
Frolov A, Chakraborty S and Rowley D: In vitro dorsal root ganglia
and human prostate cell line interaction: Redefining perineural
invasion in prostate cancer. Prostate. 49:213–223. 2001.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Godbout JP and Glaser R: Stress-induced
immune dysregulation: Implications for wound healing, infectious
disease and cancer. J Neuroimmune Pharmacol. 1:421–427.
2006.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G,
Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, et al:
Surgical stress promotes tumor growth in ovarian carcinoma. Clin
Cancer Res. 15:2695–2702. 2009.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, et al: Chronic stress promotes tumor growth and angiogenesis in
a mouse model of ovarian carcinoma. Nat Med. 12:939–944.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
68
|
Entschladen F, Drell TL IV, Lang K, Joseph
J and Zaenker KS: Tumour-cell migration, invasion, and metastasis:
Navigation by neurotransmitters. Lancet Oncol. 5:254–258.
2004.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Geldof AA, Van Haarst EP and Newling DW:
Neurotrophic factors in prostate and prostatic cancer. Prostate
Cancer Prostatic Dis. 1:236–241. 1998.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Ricci A, Greco S, Mariotta S, Felici L,
Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A and
Barbolini G: Neurotrophins and neurotrophin receptors in human lung
cancer. Am J Respir Cell Mol Biol. 25:439–446. 2001.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Dollé L, El Yazidi-Belkoura I,
Adriaenssens E, Nurcombe V and Hondermarck H: Nerve growth factor
overexpression and autocrine loop in breast cancer cells. Oncogene.
22:5592–5601. 2003.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Chédotal A, Kerjan G and Moreau-Fauvarque
C: The brain within the tumor: New roles for axon guidance
molecules in cancers. Cell Death Differ. 12:1044–1056.
2005.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Sofroniew MV, Howe CL and Mobley WC: Nerve
growth factor signaling, neuroprotection, and neural repair. Annu
Rev Neurosci. 24:1217–1281. 2001.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Melincovici CS, Boşca AB, Şuşman S,
Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL and Mihu CM:
Vascular endothelial growth factor (VEGF)-key factor in normal and
pathological angiogenesis. Rom J Morphol Embryol. 59:455–467.
2018.PubMed/NCBI
|
|
75
|
Deyama S, Bang E, Kato T, Li XY and Duman
RS: Neurotrophic and antidepressant actions of brain-derived
neurotrophic factor require vascular endothelial growth factor.
Biol Psychiatry. 86:143–152. 2019.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kutcher ME, Klagsbrun M and Mamluk R: VEGF
is required for the maintenance of dorsal root ganglia blood
vessels but not neurons during development. FASEB J. 18:1952–1954.
2004.PubMed/NCBI View Article : Google Scholar
|
